Celebrity Skincare Lines: Whose Name Is Really On It?
Rihanna has skincare. So does Kylie Jenner, Jennifer Lopez, Pharrell Williams, Victoria Beckham, and seemingly every other celebrity with a devoted following.
Rihanna has skincare. So does Kylie Jenner, Jennifer Lopez, Pharrell Williams, Victoria Beckham, and seemingly every other celebrity with a devoted following. But what you’re actually buying is rarely what the marketing suggests.
The Contract Manufacturing Reality
Most celebrity skincare lines don’t involve celebrities in formulation. What happens is simpler and more transactional:
A celebrity (or more accurately, their business team) approaches a contract manufacturer — sometimes called a private label manufacturer or turnkey lab. These companies specialise in developing and producing cosmetics for brands that don’t have their own manufacturing facilities.
The manufacturer presents existing formulas from their library. The celebrity’s team picks products, maybe requests minor adjustments (add a bit of this, change that fragrance), approves packaging, and attaches the celebrity’s name and story.
The same contract manufacturer might produce products for dozens of different “brands” — some celebrity-fronted, some not. The formulas can be nearly identical, just differently packaged and priced.
The White-Label Economy
White-labelling is the industry term for this practice. A manufacturer creates a formula, then sells it to multiple brands who each market it as their own unique product.
This isn’t inherently bad. Contract manufacturing allows smaller brands to exist without the massive capital investment of building their own labs and production facilities. Many legitimate skincare brands started this way — what separates a good formula from a mediocre one has nothing to do with who owns the factory.
What’s dishonest is the marketing narrative. When a celebrity talks about “their” skincare line like they personally developed each formula through years of research and testing, that’s usually fiction. The celebrity approved the products. They didn’t create them.
The Involvement Spectrum
Celebrity involvement in “their” skincare ranges from genuine to non-existent:
Licensing deals: The celebrity lends their name and likeness. That’s it. A company handles everything — formulation, manufacturing, marketing, distribution. The celebrity shows up for promotional content and collects royalties. This is the most common arrangement.
Approval-level involvement: The celebrity reviews proposed products, chooses from options, provides feedback on textures or scents. They have opinions, but they’re not driving formulation decisions. They’re a customer with veto power.
Creative direction: Some celebrities genuinely care about product development. They work with formulators, request specific ingredients or results, and iterate on products. The formulation expertise still comes from professionals, but the direction comes from the celebrity. This is rarer than marketing suggests.
Actual expertise: Occasionally, a celebrity brings genuine knowledge — perhaps from years of working with makeup artists and dermatologists, or from personal obsession with skincare. Their input has real value. This is the exception, not the rule.
The Marketing Machine
What celebrity branding actually sells is aspiration. You’re not buying what the celebrity uses — you’re buying the fantasy of access to their world.
The celebrity with flawless skin crediting their own product line ignores the reality: they have aestheticians, dermatologists, facialists, and access to treatments most consumers can’t afford. Their skin looks that way because of professional intervention and genetic luck, not because of the £40 serum with their name on it. It’s the same gifted-product, undisclosed-relationship playbook that props up half the skincare recommendations on your feed.
The origin stories are particularly cynical. “I couldn’t find products that worked for me, so I created my own” — from someone with unlimited access to the world’s best skincare brands and personal dermatologists. The narrative is designed for relatability it doesn’t actually possess.
The Price Disconnect
Celebrity skincare often occupies an awkward price tier: too expensive to be impulse purchases, too cheap to signal genuine luxury formulation.
The pricing reflects brand value, not product value. You’re paying for the celebrity association — the feeling of buying into their lifestyle, much like paying for the jar rather than what’s in it. The actual formula might be comparable to products at half the price from brands without celebrity markup.
Conversely, some celebrity lines price low to maximise volume — the goal is mass-market penetration and brand licensing revenue, not per-unit margin. These products often use the simplest, cheapest formulations that still perform acceptably.
Neither pricing strategy correlates with actual product quality. Price reflects business model, not formulation investment.
The Ingredient Truth
Most celebrity skincare lines contain the same ingredients as non-celebrity products because they’re made by the same manufacturers using similar base formulas.
The “hero ingredient” featured in marketing is usually present in dozens of other products. The “proprietary blend” is often a minor variation of standard formulas. The “revolutionary approach” is standard cosmetic science with a press release attached.
Some celebrity lines do include interesting formulations — usually when they’ve partnered with reputable labs and given genuine creative direction. But these are exceptions. The default is competent but unremarkable products distinguished primarily by packaging and endorsement.
The Exit Strategy
For many celebrity brands, the goal isn’t building a long-term skincare company. It’s building something sellable.
Launch with celebrity power, generate buzz, achieve impressive initial sales, then sell to a larger cosmetics conglomerate. The celebrity extracts value; the acquiring company gets a brand with built-in recognition; consumers continue buying what’s now essentially a trademark attached to corporate-standard products.
This isn’t unique to celebrity brands — it’s how much of the beauty industry works. But the celebrity involvement makes the acquisition exit particularly lucrative and particularly likely to change what the brand actually offers, leaving fans with the same parent-company reshuffle that hits any acquired indie label.
What To Actually Consider
If you’re considering a celebrity skincare purchase, ignore the celebrity. Evaluate the product on its own merits:
What are the actual ingredients? Read the list. Are actives at therapeutic concentrations? Is the formula sophisticated or basic? How does it compare to non-celebrity alternatives at the same price point?
Who manufactures it? This information isn’t always easy to find, but sometimes the manufacturing partner is disclosed. Research them. What else do they make? What’s their reputation in the industry?
What specific claims are being made? Are they backed by anything beyond the celebrity’s assertion? Independent testing? Published research on key ingredients? Or is it just “this worked for me”?
What would you pay without the name? Look at the formula, the packaging, the size. If this exact product didn’t have a famous face attached, what would it be worth to you? If the answer is significantly less than the asking price, you’re paying for marketing.
The Bottom Line
Celebrity skincare is primarily a marketing category, not a formulation category. The celebrity name gets you to look; the product itself is usually contract-manufactured, comparable to numerous alternatives, and priced for brand value rather than formula quality.
None of this means celebrity skincare is automatically bad. Some of it is perfectly good. Some of it is even innovative. But the celebrity endorsement tells you nothing about product quality — it only tells you about marketing strategy.
Buy skincare based on what’s in the bottle, not whose name is on it. The celebrity’s skin doesn’t look that way because of the products they’re selling you. And their involvement in those products is almost certainly less than the narrative suggests.